Mechanistically, loss of integrin α6 reduces the activated Akt (T308) under the suspended condition, and suppression of Akt activation using LY294002 and Wortmannin hampers the motility capacity of ESCC cells. This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.